• Monday, April 22, 2024 @ 8:00 am

ten23 health, a leading Swiss contract development and manufacturing organization, today announced the release of its 2023 Fairstainability Impact Report which outlines major progress on its sustainability goals.

ten23 health combines Sustainability and Fairness reporting into “Fairstainability”. As a Swiss-based organization, ten23 health recognizes the importance of environmental stewardship and social responsibility - its mission is to drive positive change in the pharmaceutical and CDMO industry. The 2023 Fairstainability Impact Report transparently provides the current status of key parameters and progress towards achieving its sustainability goals. 

“We are incredibly proud to announce significant progress on our sustainability agenda with the release of our third Fairstainability Report,” said Prof. Dr. Hanns-Christian Mahler, Chief Enablement Officer (CEO) at ten23 health. “Patients, People and Planet are our central commitments, and sustainability is at the core of everything we do.”

Highlights of the 2023 Fairstainability Report include: 

Reduction in carbon footprint and net positive operations: ten23 health has reduced its carbon footprint intensity (scope 1 and 2 GHG emissions/revenue) by 44% since 2021 and is expecting to meet its 50% reduction target one year earlier than planned. Initiatives include energy-efficient manufacturing processes, reduction of energy consumption, use of renewable energy sources, and optimization of transportation logistics. 104% of unavoidable total operational GHG emissions were compensated, with Atmosfair, Generation Forest and direct carbon capture via Climeworks. 

Waste reduction efforts: The company has diverted 43% of waste from disposal in 2023, up from 34% in 2022. Waste reduction strategies include recycling programs and waste minimization initiatives such as separation of waste and switching to reusable materials where possible. We also offset 150% of our plastic waste sent to incineration by our partnership with Seven Clean Seas, which removes plastics from the ocean. 

Fairness: ten23 health is committed to fairness and equality, we have 48% women employees and a certified “no gender pay gap”.  

Community engagement: the company actively engages with local communities and their employees through various initiatives, including employee volunteer programs like Cleanup Day, internal sustainability workshops, personal footprint assessment, training and offsetting. 

Certifications & Awards: in 2023, ten23 obtained the EcoVadis Silver medal as top 13% in our industry category, won 2nd place in the “Swiss HR award” and 3rd place of the “modern work award”. We were also awarded the Pride Champion Gold Award in 2023. 

The release of 2023 Fairstainability Report underscores ten23 health’s dedication and commitment to transparency and accountability in its Fairness and Sustainability efforts. By continually assessing its environmental and social impact, the company strives to be a leader and disruptor in sustainable pharmaceutical manufacturing. 

To access the full 2023 Fairstainability Report and learn more about ten23 health’s sustainability initiatives, visit the company’s website at Patients, People, Planet | ten23 health 

You may also be interested in